Sign inJoin waitlistJoin the waitlist

Cara Wilson

Professor of Medicine, Division of Infectious Diseases · University of Colorado School of Medicine

Credentials: · · ·

History

University of Colorado School of Medicine
Present

Massachusetts General Hospital
1993–1995
Johns Hopkins University School of Medicine
1988–1991
University of Virginia School of Medicine
1984–1988
Duke University
1980–1984

Research

Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment
The Journal of Infectious Diseases · 2014 · 489 citations
An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia
Mucosal Immunology · 2014 · Last of 13 authors · 428 citations
Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction
The Journal of Immunology · 2007 · 220 citations

Martin McCarter
22 papers
Michael Lederman
7 papers
Thomas Campbell
7 papers
Brett Williams
6 papers
EC
Elizabeth Connick
6 papers
Jay Liu
6 papers · 2 as a fellow
Jeffrey Jacobson
6 papers
Kristine Erlandson
6 papers
EB
Eli Boritz
5 papers · 1 as a resident
Gregory Austin
5 papers
Jon Kibbie
5 papers
Michael Lotze
5 papers

Grants

Medical Scientist Training Program
National Institute of General Medical Sciences · T32
Contact PI · $2.1M · University of Colorado Denver
2023–2028
HIV-1 Vpr and Mucosal Immunopathogenesis
National Institute of Allergy and Infectious Diseases · R21
PI · $429K · University of Colorado Denver
2026–2028
Gut Microbiota Dynamics, Exercise and Physical Function Among Older People with HIV
National Institute on Aging · R21
Contact PI · $429K · University of Colorado Denver
2025–2027
The Public Mucosal Antibody Repertoire in HIV-1 Infection
National Institute of Allergy and Infectious Diseases · R21
PI · $405.6K · University of Colorado Denver
2024–2026

Clinical trials

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication
Study chair · Withdrawn
National Institute of Allergy and Infectious Diseases (NIAID)